Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications.

× No keyword cloud information.

57 in total

Review 1. Sitagliptin: a review of its use in patients with type 2 diabetes mellitus.

Authors: Greg L Plosker
Journal: Drugs Date: 2014-02 Impact factor: 9.546

Review 2. Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes.

Authors: Bo Ahrén
Journal: World J Diabetes Date: 2014-02-15

Review 3. The current state of GPCR-based drug discovery to treat metabolic disease.

Authors: Kyle W Sloop; Paul J Emmerson; Michael A Statnick; Francis S Willard
Journal: Br J Pharmacol Date: 2018-03-25 Impact factor: 8.739

4. Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes.

Authors: David A D'Alessio; Amanda M Denney; Linda M Hermiller; Ronald L Prigeon; Julie M Martin; William G Tharp; Monica Liqueros Saylan; Yanling He; Beth E Dunning; James E Foley; Richard E Pratley
Journal: J Clin Endocrinol Metab Date: 2008-10-28 Impact factor: 5.958

Review 5. Impact of hypoglycemic agents on myocardial ischemic preconditioning.

Authors: Rosa Maria Rahmi Garcia; Paulo Cury Rezende; Whady Hueb
Journal: World J Diabetes Date: 2014-06-15

6. Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats.

Authors: Kosuke Kaji; Hitoshi Yoshiji; Yasuhide Ikenaka; Ryuichi Noguchi; Yosuke Aihara; Akitoshi Douhara; Kei Moriya; Hideto Kawaratani; Yusaku Shirai; Junichi Yoshii; Koji Yanase; Mitsuteru Kitade; Tadashi Namisaki; Hiroshi Fukui
Journal: J Gastroenterol Date: 2013-03-12 Impact factor: 7.527

7. Sitagliptin reduces hyperglycemia and increases satiety hormone secretion more effectively when used with a novel polysaccharide in obese Zucker rats.

Authors: Raylene A Reimer; Gary J Grover; Lee Koetzner; Roland J Gahler; Prateek Juneja; Michael R Lyon; Simon Wood
Journal: J Nutr Date: 2012-08-22 Impact factor: 4.798

8. Sitagliptin downregulates retinol-binding protein 4 and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model.

Authors: Honglin Hu; Min Xu; Renjuan Qi; Youmin Wang; Changjiang Wang; Jiongjiong Liu; Li Luo; Li Xia; Zhaohui Fang
Journal: Int J Clin Exp Med Date: 2015-10-15

Review 9. Rosiglitazone : a review of its use in type 2 diabetes mellitus.

Authors: Emma D Deeks; Susan J Keam
Journal: Drugs Date: 2007 Impact factor: 9.546

10. The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study.

Authors: Adrian Vella; Gerlies Bock; Paula D Giesler; Duane B Burton; Denise B Serra; Monica Ligueros Saylan; Carolyn F Deacon; James E Foley; Robert A Rizza; Michael Camilleri
Journal: Clin Endocrinol (Oxf) Date: 2008-03-10 Impact factor: 3.478